Luye Innomind Pharma Shijiazhuang

Luye Innomind Pharma (Shijiazhuang) is a specialized pharmaceutical subsidiary of the Luye Pharma Group, serving as a primary innovation and manufacturing hub in Shijiazhuang, China. The company focuses on advanced drug delivery systems, specifically mastering the development and large-scale production of long-acting injectable formulations, microspheres, and liposomes. Its commercial and clinical portfolio is heavily weighted toward central nervous system (CNS) disorders and oncology, featuring products like Rykindo for schizophrenia. The facility operates under international GMP standards to support Luye Pharma's expansion into global markets, including the United States and Europe.